UNSPSC 41181889: Horse epithelium allergenic extract

In this classification, this entry connotes an extract made of Horse epithelium used in an Immunological Allergenic test.

UNSPSC 41181889 Horse epithelium allergenic extract is a Commodity code that nominally denotes equine allergen preparations used in diagnostic and therapeutic immunology. State and local procurement activity under this code, however, shows little alignment with the abstract scope; recent solicitations tagged to this code are actually acquiring emergency medical services pharmaceuticals, pharmacy benefits management, naloxone distribution, and primary care medication dispensing—products and services unrelated to allergenic extracts. The Washington State Department of Corrections issued an RFQQ in September 2026 for parenteral nutrition solutions, intravenous products, and controlled substances for incarcerated individuals across eight facilities statewide, while the New Jersey Department of the Treasury solicited naloxone 4mg nasal spray for distribution to first responders, schools, libraries, and harm reduction agencies statewide. The City of Tucson Fire Department sought basic and advanced life support pharmaceuticals, vending machines, and inventory management software through an RFP with federal compliance obligations including prevailing wage and Buy America. DeKalb Public Health in Georgia issued two separate RFQs for primary care medication dispensing to Ryan White program patients. Issuing bodies include state departments (Washington Corrections, New Jersey Treasury), county health agencies (DeKalb Public Health), and municipal fire departments (Tucson, Forsyth County).

Geographic activity spans Washington, New Jersey, Georgia, Florida, Texas, Arizona, and Illinois, with particular concentration in the Southeast and Mid-Atlantic. The New Jersey naloxone contract (solicitation 26DPP01283, October 27, 2026 deadline) is the largest recent activity—historical volumes of 265,500 cartons annually at $7.8 million—managed through cooperative purchasing under state opioid response grant funding. The Illinois joint purchase master contract (JPMC) for Narcan extended through December 31, 2026 with an estimated $9 million value for the six-month extension and cumulative spending of approximately $65 million over 61 months. The Washington DOC parenteral contract (RFQQ due October 7, 2026) spans three regions with multiple award potential and firm pricing for two years. The Tucson Fire Department RFP (due June 24, 2026) encompassed 251 line items with estimated annual usage reaching 120,000 units for certain products and required 95 percent fill rates with same-day emergency delivery capability. The code shows a fundamental mislabeling issue—the equine allergen extract taxonomy does not match the pharmaceutical supply and services work actually being solicited, suggesting either data-entry error or incorrect UNSPSC tagging by issuing bodies.